Insider Transactions in Q2 2022 at Mesa Laboratories Inc (MLAB)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 21
2022
|
John Sakys CFO |
SELL
Open market or private sale
|
Direct |
722
-7.68%
|
$135,736
$188.22 P/Share
|
|
Jun 21
2022
|
John Sakys CFO |
BUY
Grant, award, or other acquisition
|
Direct |
1,667
+15.06%
|
-
|
|
Jun 21
2022
|
Gregory Dinoia SVP Commercial |
SELL
Open market or private sale
|
Direct |
555
-13.25%
|
$104,340
$188.22 P/Share
|
|
Jun 21
2022
|
Gregory Dinoia SVP Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
1,278
+23.38%
|
-
|
|
Jun 21
2022
|
Brian David Archbold SVP Operations |
SELL
Open market or private sale
|
Direct |
392
-32.53%
|
$73,696
$188.22 P/Share
|
|
Jun 21
2022
|
Brian David Archbold SVP Operations |
BUY
Grant, award, or other acquisition
|
Direct |
868
+41.87%
|
-
|
|
Jun 21
2022
|
Gary M Owens President and CEO |
SELL
Open market or private sale
|
Direct |
1,756
-7.51%
|
$330,128
$188.22 P/Share
|
|
Jun 21
2022
|
Gary M Owens President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
4,055
+14.77%
|
-
|
|
Jun 17
2022
|
John Sakys CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
173
-2.19%
|
$32,005
$185.57 P/Share
|
|
Jun 17
2022
|
John Sakys CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
392
+4.72%
|
-
|
|
Jun 17
2022
|
Gregory Dinoia SVP Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
173
-5.61%
|
$32,005
$185.57 P/Share
|
|
Jun 17
2022
|
Gregory Dinoia SVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
391
+11.25%
|
-
|
|
Jun 17
2022
|
Brian David Archbold SVP Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
155
-31.5%
|
$28,675
$185.57 P/Share
|
|
Jun 17
2022
|
Brian David Archbold SVP Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
338
+40.72%
|
-
|
|
Jun 17
2022
|
Gary M Owens President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
740
-3.69%
|
$136,900
$185.57 P/Share
|
|
Jun 17
2022
|
Gary M Owens President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,685
+7.74%
|
-
|
|
Jun 15
2022
|
John James Sullivan Director |
SELL
Payment of exercise price or tax liability
|
Direct |
14
-0.06%
|
$2,590
$185.7 P/Share
|
|
Jun 15
2022
|
John James Sullivan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30
+0.12%
|
-
|
|
Jun 15
2022
|
John Bradley Schmieder Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30
+0.04%
|
-
|
|
Jun 15
2022
|
Laboratories Inc /Co/ Mesa Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30
+0.1%
|
-
|
|
Jun 15
2022
|
Evan Guillemin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30
+0.1%
|
-
|
|
Jun 09
2022
|
John James Sullivan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,001
+3.87%
|
$70,070
$70.56 P/Share
|
|
Jun 07
2022
|
John James Sullivan Director |
SELL
Open market or private sale
|
Direct |
5,192
-17.87%
|
$1,074,744
$207.76 P/Share
|
|
Jun 07
2022
|
John James Sullivan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,192
+15.16%
|
$363,440
$70.56 P/Share
|
|
Apr 20
2022
|
John Sakys CFO |
SELL
Open market or private sale
|
Direct |
72
-0.95%
|
$18,000
$250.44 P/Share
|
|
Apr 20
2022
|
John Sakys CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
72
+0.94%
|
$3,672
$51.85 P/Share
|